NOVO NORDISK A S (NVO) Form 6-K — Oct 19, 2026
Novo Nordisk filed its weekly share repurchase progress report, disclosing that it bought back 1,225,000 B shares between 12 and 16 October 2026 at average prices of roughly DKK 254.86-260.67 per share. Under the programme initiated 6 May 2026 (part of the broader DKK 15 billion, 12-month buyback that began 4 February 2026), the company has now repurchased 24,315,000 B shares for DKK 7,075,024,314. Since February, total repurchases stand at 39,074,179 B shares at an average price of DKK 278.32.
Key figures
- Total shares
- 4,465,000,000 A and B shares
- Programme size
- DKK 15 billion over 12 months beginning 4 February 2026
- Treasury shares
- 53,114,876 B shares, 1.2% of share capital
- Week transactions
- 1,225,000 shares (12-16 Oct 2026) for ~DKK 316.1 million
- May programme capacity
- DKK 11,200,000,010.45 (6 May 2026 to 1 February 2027)
- Ytd repurchases since feb 2026
- 39,074,179 B shares at avg DKK 278.32, value DKK 10,875,024,304
- Accumulated under may programme
- 24,315,000 B shares for DKK 7,075,024,314
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.